Biomarkers in Critical Care,An Issue of Critical Care Clinics E-Book, 1st Edition
著者 :
Edited by Mitchell Levy, MD, MCCM, FCCP
This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are
...view more
This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers.
This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers.
著者情報
Edited by Mitchell Levy, MD, MCCM, FCCP, Systemwide Director, Critical Care Medicine Lifespan Health and Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Warren Alpert Medical School at Brown University, Providence, Rhode Island
Edited by Mitchell Levy, MD, MCCM, FCCP, Systemwide Director, Critical Care Medicine Lifespan Health and Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Warren Alpert Medical School at Brown University, Providence, Rhode Island
https://shop.elsevier.jp/biomarkers-in-critical-carean-issue-of-critical-care-clinics-e-book-9780323683159.html301942Biomarkers in Critical Care,An Issue of Critical Care Clinics E-Bookhttps://secure-ecsd.elsevier.com/covers/80/Tango2/large/9780323683159.jpg1001610016JPYInStock/Medicine & Surgery/Critical Care/eBooks/Medicine/Critical Care/eBooks/eBooks/Medicine/Critical Care/Medicine/Critical Care/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book433510443887245054568505466552550405259849580353159368005936822593682759368321418269243350884886536505455351451205259833579989258035265936799593680959368235936828This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers. This issue of Critical Care Clinics, guest edited by Dr. Mitchell M. Levy, focuses on Biomarkers in Critical Care. This is one of four issues each year selected by the series consulting editor, Dr. John Kellum. Articles in this issue include, but are not limited to: The History of Biomarkers; Biomarkers for Identifying Infection; Procalcitonin: Where Are We Now?; Soluble TREM-1: Diagnosis or Prognosis?; Lubricin as a Biomarker in Sepsis; Check Point Inhibitors and Their Role in Immunosuppression in Sepsis; Metabolomics and the Microbiome as Biomarkers in Sepsis; Lactate: Where Are We Now?; Predicting Renal Dysfunction; Biomarkers in the Evolution of ARDS; Biomarkers and RV Dysfunction; Biomarkers and Precision Medicine: State of the Art; The Use of Biomarkers for Population Homogeneity in Clinical Trials; and The Future of Biomarkers.00add-to-cart97803236831592019専門医Edited by Mitchell Levy, MD, MCCM, FCCP20201E-BookOtherElsevier2402019/11/28IN STOCKEdited by <STRONG>Mitchell Levy</STRONG>, MD, MCCM, FCCP, Systemwide Director, Critical Care Medicine Lifespan Health and Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Warren Alpert Medical School at Brown University, Providence, Rhode IslandE-BookE-BookThe Clinics: Internal MedicineS013Critical Care, Medicine米国いいえいいえいいえいいえいいえ選択してください選択してくださいいいえいいえ選択してください
